SEP 4, 2026 · JOURNAL ARTICLE
Oncofetal antigens as emerging targets in chimeric antigen receptor (CAR)-T cell-based immunotherapies: opportunities and challenges
Frontiers in Cell and Developmental Biology
A narrative mini-review synthesizing biological rationale, clinical trial experience, and emerging strategies for oncofetal antigen-targeted CAR-T therapies, offering expert perspective on opportunities and limitations rather than novel empirical findings.
Study details
DesignNarrative mini-review